July/August 2024 • PharmaTimes Magazine • 3
In many ways UK pharma and the life sciences are radical outliers – transcending politics and thriving irrespective of the sitting administration.
Indeed, the pandemic was a case study in how the health of a nation is not always in the hands of bungling politicians but in the laps of lab coats.
And while Boris Johnson clumsily wrestled away the narrative – implying that he was ‘responsible’ for the vaccine – history and the real story is on the side of pharma.
The reality is, pharma wizardry happens as a matter of course, seemingly beyond the gimmicks and befuddlement of the campaign trail.
But it is not completely immune to what happens on July 4. There will be the inevitable remixing of governance and, of course, the tossing around of the ultimate hot potato.
Gimme an ‘N’, gimme an ‘H’ and gimme an ‘S’. Put them together and what have you got? A crumbling edifice, barely surviving on the thin fumes of sentimentality. Yep, make no mistake – the bold reinvention of public health needs to be truly transformational, inviting big tech, igniting AI and upholding inclusion.
For the British, dismantling the NHS as we know it may be a bitter pill to swallow, but it’s a necessary dose. What must remain of the NHS, however, is its principle. Without that we are doomed.
So, while Ed Davey cascades down a waterslide, while Rishi Sunak wears suspiciously new Adidas trainers and while Kier Starmer occasionally mentions 14 years’ of hurt, we have a decision to make.
Whichever box you tick, do it with a flourish,
John Pinching
editor
PharmaTimes Media Ltd,
Mansard House, Church Road,
Little Bookham, Surrey, KT23 3JG
Tel: +44 (0)20 7240 6999
www.pharmatimes.com
Twitter: @PharmaTimes
EDITORIAL
John Pinching / editor
john.pinching@pharmatimes.com
Iona Everson / group managing editor
iona.everson@pharmatimes.com
Karl Equi / executive director
karl.equi@pharmatimes.com
SALES & MARKETING
Tara Lovegrove / business director
tara.lovegrove@pharmatimes.com
Luci Sargood / business manager
luci.sargood@pharmatimes.com
SUBSCRIPTIONS/REPRINTS
Digital and paper copies available
free to qualifying readers:
www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK
and £100.00 overseas per annum.
Views expressed by the contributors
do not necessarily represent those of
the publisher, editor or staff.
Material may not be reproduced in any form
without the publisher’s written permission.
© Copyright 2024 PharmaTimes Magazine.
All rights reserved. PharmaTimes Magazine
is published by PharmaTimes Media Ltd,
which is registered as a limited company
in England; No 09019637.
One of our most prestigious awards – ‘Clinical Researcher of the Year – The Americas’ closes for entry on 5 August 2024. Simply search ‘Clinical Researcher The Americas’ and follow your dream.